Abstract
PurposeTo investigate the agreement and reliability of anterior segment optical coherence tomography (AS-OCT) and Scheimpflug imaging in measuring the distance from the anterior edge of an iris-fixated phakic intraocular lens (IF-pIOL) to the corneal endothelium.MethodsAnterior segment configuration was assessed in a total of 62 eyes of which 25 hyperopic and 37 myopic eyes, all corrected with an IF-pIOL. Measurements were performed by two independent observers using AS-OCT (Visante, Model 1000, Carl Zeiss Meditec Inc.) and Scheimpflug imaging (Pentacam HR, Oculus Optikgerate). The distance from the anterior edge of the pIOL to the endothelium was measured in five different positions using both modalities with their corresponding pIOL software. The measurements as well as the inter- and intra-observer reliability of the two imaging modalities were then compared.ResultsDistance measurements for all positions performed by AS-OCT were found to be significantly larger than those performed by Scheimpflug imaging, with mean differences ranging from 0.11 to 0.22 mm. Both instruments exhibited good inter- and intra-observer reliability.ConclusionAnterior pIOL edge to endothelium distance measurements by AS-OCT and Scheimpflug imaging have good intra- and inter-observer reliability. However, as AS-OCT provides larger measurements, these two modalities cannot be used interchangeably. Correction of this difference might be essential for proper decision-making during pre-operative screening for pIOL implantation and post-operative safety monitoring.
Highlights
Phakic intraocular lens implantation has proven to be safe and effective for the correction of a broad range of ametropia [1, 2]
The Artisan lens (Ophtec BV, Groningen, the Netherlands) is an iris-fixated (IF) Phakic intraocular lens (pIOL) that has been used successfully to correct moderate to high myopia, hyperopia, and astigmatism since 1991
The power of the Artisan lenses implanted ranged from + 12.00 to − 23.50 diopters
Summary
Phakic intraocular lens (pIOL) implantation has proven to be safe and effective for the correction of a broad range of ametropia [1, 2]. Graefes Arch Clin Exp Ophthalmol (2021) 259:231–238 endothelial cell (EC) loss, especially in the case of IF-pIOL. As this risk has been shown to be negatively correlated to the anterior chamber depth, the position of an IF-pIOL in the anterior chamber is one of the main safety parameters in both pre-operative screening and follow-up [1, 4,5,6,7,8,9]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Graefe's Archive for Clinical and Experimental Ophthalmology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.